LeMaitre Vascular Inc (LMAT) - Total Liabilities
Based on the latest financial reports, LeMaitre Vascular Inc (LMAT) has total liabilities worth $219.15 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does LeMaitre Vascular Inc generate cash to assess how effectively this company generates cash.
LeMaitre Vascular Inc - Total Liabilities Trend (2001–2024)
This chart illustrates how LeMaitre Vascular Inc's total liabilities have evolved over time, based on quarterly financial data. Check LMAT financial resilience to evaluate the company's liquid asset resilience ratio.
LeMaitre Vascular Inc Competitors by Total Liabilities
The table below lists competitors of LeMaitre Vascular Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aarti Industries Limited
NSE:AARTIIND
|
India | Rs59.90 Billion |
|
Worthington Steel Inc
NYSE:WS
|
USA | $803.10 Million |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥4.40 Billion |
|
BaoViet Holdings
VN:BVH
|
Vietnam | ₫266.30 Trillion |
|
Werner Enterprises Inc
NASDAQ:WERN
|
USA | $1.50 Billion |
|
WK Kellogg Co
NYSE:KLG
|
USA | $1.78 Billion |
|
Cal-Comp Electronics (Thailand) Public Company Limited
BK:CCET
|
Thailand | ฿54.15 Billion |
Liability Composition Analysis (2001–2024)
This chart breaks down LeMaitre Vascular Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LMAT company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LeMaitre Vascular Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LeMaitre Vascular Inc (2001–2024)
The table below shows the annual total liabilities of LeMaitre Vascular Inc from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $214.53 Million | +338.90% |
| 2023-12-31 | $48.88 Million | +15.62% |
| 2022-12-31 | $42.27 Million | +9.38% |
| 2021-12-31 | $38.65 Million | -51.83% |
| 2020-12-31 | $80.24 Million | +99.60% |
| 2019-12-31 | $40.20 Million | +75.91% |
| 2018-12-31 | $22.85 Million | +38.06% |
| 2017-12-31 | $16.55 Million | +14.76% |
| 2016-12-31 | $14.42 Million | +12.51% |
| 2015-12-31 | $12.82 Million | -3.50% |
| 2014-12-31 | $13.29 Million | -4.63% |
| 2013-12-31 | $13.93 Million | +36.94% |
| 2012-12-31 | $10.17 Million | +33.86% |
| 2011-12-31 | $7.60 Million | -30.40% |
| 2010-12-31 | $10.92 Million | +25.60% |
| 2009-12-31 | $8.69 Million | +0.49% |
| 2008-12-31 | $8.65 Million | -31.15% |
| 2007-12-31 | $12.56 Million | +100.59% |
| 2006-12-31 | $6.26 Million | -4.10% |
| 2005-12-31 | $6.53 Million | +14.84% |
| 2004-12-31 | $5.69 Million | +21.18% |
| 2002-12-31 | $4.69 Million | -6.94% |
| 2001-12-31 | $5.04 Million | -- |
About LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more